Thelansis

 Cancer pain is a common experience for many individuals diagnosed with cancer or undergoing cancer treatment. The primary cause of cancer pain is the tumor, which can compress surrounding tissues such as nerves, bones, spinal cord, and organs. It can also result from diagnostic tests or treatments, such as biopsies, spinal taps, radiation therapy, chemotherapy, and surgery. The pain can be either acute or chronic. Acute pain is typically short-lived due to injury or treatment, while chronic pain can be persistent and may result from nerve changes due to cancer or cancer treatment. The World Health Organization has developed a three-step analgesia guide for cancer pain management, which includes non-opioids, weak opioids, and strong opioids. ·        Pain prevalence rates were 39.3% after curative treatment; 55.0% during anticancer treatment; and 66.4% in advanced, metastatic, or terminal disease. Thelansis’s “Cancer Pain Market Outlook, Epidemiolo...

 Cancer pain is a common experience for many individuals diagnosed with cancer or undergoing cancer treatment. The primary cause of cancer pain is the tumor, which can compress surrounding tissues such as nerves, bones, spinal cord, and organs. It can also result from diagnostic tests or treatments, such as biopsies, spinal taps, radiation therapy, chemotherapy, and surgery. The pain can be either acute or chronic. Acute pain is typically short-lived due to injury or treatment, while chronic pain can be persistent and may result from nerve changes due to cancer or cancer treatment. The World Health Organization has developed a three-step analgesia guide for cancer pain management, which includes non-opioids, weak opioids, and strong opioids. ·        Pain prevalence rates were 39.3% after curative treatment; 55.0% during anticancer treatment; and 66.4% in advanced, metastatic, or terminal disease. Thelansis’s “Cancer Pain Market Outlook, Epidemiolo...